Growth HormoneModerate Evidence

GHRP-2

Also known as: Growth Hormone Releasing Peptide-2

Synthetic ghrelin mimetic that stimulates GH release with moderate appetite stimulation.

Benefits

6

Conditions

5

Evidence

Clinical trials, preclinical research+ studies

Source

Synthetic hexapeptide ghrelin mimetic

Overview

Synthetic ghrelin mimetic that stimulates GH release with moderate appetite stimulation.

Mechanism of Action

Binds ghrelin receptor (GHS-R1a) to trigger GH release, moderate cortisol and prolactin elevation, increases appetite via ghrelin pathway, synergistic with GHRH analogs for maximal GH pulse.

Key Benefits

  • Strong GH pulse induction
  • Increases IGF-1
  • Enhanced muscle growth
  • Improved recovery
  • Better sleep quality
  • Appetite stimulation (beneficial for some)

Clinical Applications

Growth hormone deficiencyMuscle wastingPoor appetiteRecovery from injuryAge-related GH decline

Dosing Guidelines

Subcutaneous injection

Typical Dose100-300 mcg
Frequency1-3 times daily
Duration8-12 weeks

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Moderate
Studies

Clinical trials, preclinical research

Summary

Clinical evidence for GH stimulation. Less selective than ipamorelin (affects cortisol/prolactin). Effective for GH elevation when combined with GHRH analogs.

Safety Information

Potential Side Effects

  • Increased hunger
  • Water retention
  • Numbness/tingling
  • Mild cortisol elevation

Contraindications

  • Active cancer
  • Pregnancy
  • Breastfeeding

Interactions

  • Synergistic with CJC-1295 or GHRH

Quick Facts

CategoryGrowth Hormone
SourceSynthetic hexapeptide ghrelin mimetic
Legal StatusResearch compound, not FDA approved
Gabriel Brain Score
78/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.